New Study Highlight Ketamine Treatment for Major Depression
and Why Serotonin is Key
A recent study from the Karolinska Institutet researched whether ketamine acts on the 5-HT1B serotonin receptors in the brain. This research which has also been published in the Translational Psychiatry has found that individuals who have depression also have a low density of these receptors in their brains compared to individuals who do not have depression.
The anesthetic drug ketamine has been shown, in low doses, to have a rapid effect on difficult-to-treat depression. Researchers at the Karolinska Institutet now report that they have identified a key target for the drug: specific serotonin receptors in the brain.
This study is just one example of how transformative ketamine can be for treatment-resistant depression. At Ketamine Wellness Centers, we treat a number of patients from all walks of life, as our clinical program is one of few, if not the only clinic, which combines the diagnostic tools of mental health professionals with the precision of the anesthesia community. The combination of those two professions allows us to evaluate patients and determine how effective Ketamine treatment maybe for that person or loved one.
If you’re looking to find relief or know someone is struggling with ongoing mental health, anxiety, or a chronic pain condition, please give us a call 855-KET-WELL (855-538-9355).
Also, in case you missed it, read our blog, New Study Details the Connection Between Ketamine and Cognitive Behavioral Therapy, written by our very own Clinical Administrator, Magda Villegas at Ketamine Wellness Centers Tucson. This blog will give you additional insight on the benefits of Cognitive Behavioral Therapy in conjunction with Ketamine therapy.